Contribution of anorexia to tissue wasting in cachexia

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Opinion in Supportive and Palliative Care

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SPC.0b013e32833e4aa5PMID 20693907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus on cachexia definitions.

  2010cited by this paper
• Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations.

  2010cited by this paper
• A Pharmacologically Active Monoclonal Antibody against the Human Melanocortin-4 Receptor: Effectiveness After Peripheral and Central Administration

  2010cited by this paper
• Factors associated with nutritional status in liver transplant patients who survived the first year after transplantation

  2010cited by this paper
• Relationship Between Body Mass Index, Nutrition, Strength, and Function in Elderly Individuals With Chronic Obstructive Pulmonary Disease

  2010cited by this paper
• Nutritional status: its influence on the outcome of patients undergoing liver transplantation

  2010cited by this paper
• The cancer anorexia-cachexia syndrome: myth or reality?

  2010cited by this paper
• Appetite and gastrointestinal motility: role of ghrelin-family peptides.

  2010cited by this paper
• Tryptophan in wasting diseases: at the crossing between immune function and behaviour

  2009cited by this paper
• Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment.

  2009cited by this paper
• Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice

  2009cited by this paper
• Malnutrition and wasting in renal disease

  2009cited by this paper
• Mechanisms and treatment of anorexia in end-stage renal disease patients on hemodialysis.

  2009cited by this paper
• Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile.

  2008cited by this paper
• Cachexia: a new definition.

  2008cited by this paper
• Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia.

  2008cited by this paper
• Neural control of the anorexia-cachexia syndrome.

  2008cited by this paper
• Modulation of melanocortin signaling ameliorates uremic cachexia.

  2008cited by this paper
• Body mass index and mortality in heart failure: a meta-analysis.

  2008cited by this paper
• Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.

  2007cited by this paper
• Is des-acyl ghrelin contributing to uremic anorexia?

  2007cited by this paper
• Anorexia in Hemodialysis Patients: The Possible Role of Des-Acyl Ghrelin

  2007cited by this paper
• Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation.

  2007cited by this paper
• Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.

  2007cited by this paper
• Serotonin and the orchestration of energy balance.

  2007cited by this paper
• Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.

  2007cited by this paper
• Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy.

  2006cited by this paper
• Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study.

  2006cited by this paper
• Prevention and treatment of cancer cachexia: new insights into an old problem.

  2006cited by this paper
• Serotonin reciprocally regulates melanocortin neurons to modulate food intake.

  2006cited by this paper
• The Role of Hypothalamic Malonyl-CoA in Energy Homeostasis*

  2006cited by this paper
• The Role of Branched-Chain Amino Acids and Serotonin Antagonists in the Prevention and Treatment of Cancer Cachexia

  2006cited by this paper
• Prognosis and therapy approaches of cardiac cachexia

  2006cited by this paper
• Central nervous system control of food intake and body weight

  2006cited by this paper
• Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes

  2005cited by this paper
• Recent Advances in Understanding the Malnutrition‐Inflammation‐Cachexia Syndrome in Chronic Kidney Disease Patients: What is Next?

  2005cited by this paper
• Treatment of cachexia with ghrelin in patients with COPD.

  2005cited by this paper
• Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.

  2004cited by this paper
• Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients.

  2004cited by this paper
• Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure

  2004cited by this paper
• Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

  2004cited by this paper
• Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ

  2004cited by this paper
• Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

  2003cited by this paper
• Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies.

  2003cited by this paper
• Activation of Central Melanocortin Pathways by Fenfluramine

  2002cited by this paper
• Effects of serotonin synthesis blockade on interleukin-1 beta action in the brain of rats.

  2001cited by this paper
• Time course of short-term and long-term orexigenic effects of Agouti-related protein (86-132)

  2001cited by this paper
• Effects of serotonin synthesis blockade on interleukin-1β action in the brain of rats

  2001cited by this paper
• Melanocortin receptors: their functions and regulation by physiological agonists and antagonists

  2001cited by this paper
• Clinical course and prognosis of patients with chronic obstructive pulmonary disease.

  2000cited by this paper
• Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites

  2000cited by this paper
• Interleukins and tumor necrosis factor as inhibitors of food intake.

  1999cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Wasting as independent risk factor for mortality in chronic heart failure.

  1997cited by this paper
• Anorexia induced by cytokine interactions at pathophysiological concentrations.

  1996cited by this paper

• The Power of Drosophila in Modeling Cancer Cachexia.

  2025cites this paper
• Association between body composition parameters and treatment-related toxicities in patients with metastatic breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors.

  2025cites this paper
• Evaluation of Browning Markers in Subcutaneous Adipose Tissue of Newly Diagnosed Gastrointestinal Cancer Patients with and without Cachexia

  2022cites this paper
• Changes of gene expression in peripheral blood mononuclear cells of lung cancer patients with or without anorexia.

  2022cites this paper
• Current Screening Methods for the Risk or Presence of Malnutrition in Cancer Patients

  2022cites this paper
• Cancer and Disordered Eating Behavior: The Issue of Anorexia

  2021cites this paper
• A Pound of Flesh: What Cachexia Is and What It Is Not

  2021cites this paper
• Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia

  2021cites this paper
• Cancer-associated anorexia: Validity and performance overtime of different appetite tools among patients at their first cancer diagnosis.

  2021cites this paper
• Endocrinological and Nutritional Implications of Anorexia of Aging

  2021cites this paper
• Quality of life and its relation with nutritional status in patients with incurable cancer in palliative care

  2020cites this paper
• The Anorexia-Cachexia Syndrome: Definitions, Evaluation, and Nonpharmacological Management #386

  2020cites this paper
• Association between Growth Differentiation Factor-15 (GDF-15) Serum Levels, Anorexia and Low Muscle Mass among Cancer Patients

  2020cites this paper
• Cancer Cachexia: More Than Skeletal Muscle Wasting.

  2018cites this paper
• Inter-tissue communication in cancer cachexia

  2018cites this paper
• Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients.

  2017cites this paper
• Cachexia Stage, Patient-Generated Subjective Global Assessment, Phase Angle, and Handgrip Strength in Patients with Gastrointestinal Cancer

  2017cites this paper
• APPETITE PREDICTS INTAKE AND NUTRITIONAL STATUS IN PATIENTS RECEIVING PERITONEAL DIALYSIS.

  2016cites this paper
• Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways

  2016cites this paper
• Impaired Glucocorticoid Synthesis in Cancer Cachexia-Anorexia Syndrome in an Experimental Model

  2016cites this paper
• Enhanced activity of hormone sensitive lipase (HSL) in mesenteric but not epididymal fat correlates with higher production of epinephrine in mesenteric adipocytes in rat model of cachectic rheumatoid arthritis

  2016cites this paper
• Cancer anorexia: hypothalamic activity and its association with inflammation and appetite‐regulating peptides in lung cancer

  2016cites this paper
• Investigation of proteome alterations characteristic for tumor associated cachexia

  2015cites this paper
• Carnitine for the treatment of cachexia: Lights and shadows.

  2015cites this paper
• Nonmuscle Tissues Contribution to Cancer Cachexia

  2015cites this paper
• Anorexia assessment in patients with cancer: a crucial issue to improve the outcome.

  2015cites this paper
• Cancer cachexia: understanding the molecular basis

  2014cites this paper
• Cancer cachexia: towards integrated therapeutic interventions

  2014cites this paper
• Control of food intake and muscle wasting in cachexia.

  2013cites this paper
• Immunological and hormonal effects of exercise: implications for cancer cachexia

  2013cites this paper
• Malnutrition: the hidden killer in healthcare systems

  2013cites this paper
• The hunger hormone ghrelin in cachexia

  2013cites this paper
• Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia

  2011cites this paper
• Treatment strategies for sarcopenia and frailty.

  2011cites this paper
• Current and future pharmacologic treatment of sarcopenia.

  2011cites this paper
• Brain–immune interactions and the neural basis of disease-avoidant ingestive behaviour

  2011cites this paper
• Anorexia-cachexia syndrome in a patient with advanced gastric cancer: a case report and review of the literature

  2010cites this paper